Borg S, Nahi H, Hansson M, Lee D, Elvidge J, Persson U. Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden. AO [Internet]. 2016 May 3 [cited 2026 May 20];55(5):554-60. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/25298